Tm Bioscience reports positive results confirming utility of respiratory viral panel to detect and discriminate Influenza A-H5
Tm Bioscience Corporation announced results from clinical testing relating to high discriminating ability of the ID-Tag(TM) RVP with regards to the highly pathogenic H5 subtype of the influenza A virus. The primary aim of the European arm of the multi-national clinical study sponsored by Tm was to collect data on viruses that are underrepresented in the general population, including the H5 subtype of Influenza A. This was achieved by including archived samples in the study, which had an overall recruitment of more than 1000 unique patient specimens. According to the company, results have confirmed the ability of the ID-Tag(TM) RVP to detect the bird flu virus in all positive clinical samples tested (0% false negative rate for H5). Additionally, the majority of patient samples tested by the ID-Tag(TM) RVP across both the European and North American arms of the clinical trial were probed for Influenza A-H5. There were no false positive results observed in any of these samples.
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.